- Home
- IEX vs QGEN Comparison
IEX vs QGEN Comparison
Compare IEX & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IEX
- QGEN
- Stock Information
- Founded
- IEX 1987
- QGEN 1986
- Country
- IEX United States
- QGEN Netherlands
- Employees
- IEX N/A
- QGEN N/A
- Industry
- IEX Fluid Controls
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IEX Industrials
- QGEN Health Care
- Exchange
- IEX Nasdaq
- QGEN Nasdaq
- Market Cap
- IEX 12.6B
- QGEN 10.7B
- IPO Year
- IEX 1991
- QGEN 1996
- Fundamental
- Price
- IEX $167.92
- QGEN $43.42
- Analyst Decision
- IEX Strong Buy
- QGEN Buy
- Analyst Count
- IEX 5
- QGEN 7
- Target Price
- IEX $198.80
- QGEN $50.68
- AVG Volume (30 Days)
- IEX 666.4K
- QGEN 1.1M
- Earning Date
- IEX 10-29-2025
- QGEN 11-04-2025
- Dividend Yield
- IEX 1.69%
- QGEN 3.51%
- EPS Growth
- IEX N/A
- QGEN 334.36
- EPS
- IEX 6.32
- QGEN 1.85
- Revenue
- IEX $3,421,300,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- IEX $6.22
- QGEN $7.37
- Revenue Next Year
- IEX $3.11
- QGEN $5.65
- P/E Ratio
- IEX $26.63
- QGEN $23.25
- Revenue Growth
- IEX 7.09
- QGEN 5.32
- 52 Week Low
- IEX $153.36
- QGEN $37.63
- 52 Week High
- IEX $237.38
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- IEX 50.68
- QGEN 29.66
- Support Level
- IEX $165.40
- QGEN $43.26
- Resistance Level
- IEX $170.22
- QGEN $47.39
- Average True Range (ATR)
- IEX 3.86
- QGEN 1.09
- MACD
- IEX -0.22
- QGEN -0.60
- Stochastic Oscillator
- IEX 12.63
- QGEN 8.86
About IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).